PMH45 COST-UTILITY OF AGOMELATINE, VENLAFAXINE AND PLACEBO IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN FINLAND—ECONOMIC MODELLING STUDY USING REPRESENTATIVE POPULATION DATA
EJ Soini, TA HallinenVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74764-1
File:
PDF, 71 KB
english, 2009